ClexBio is developing next-generation tissue engineering technology. We are an early-stage company with a breakthrough proprietary technology platform for scalable, high-throughput tissue generation. Our team brings highly relevant experience from the biotech industry and expertise in cell biology, tissue culture automation, and translational research from the Harvard Weitz Lab, Yale University, the Wake Forest Institute for Regenerative Tissue Engineering, Weill Cornell Medical College, and Zimmer Biomet. ClexBio owns the patents for a highly innovative method for creating biocompatible hydrogels as well as the technology to grow large tissues from healthy human cells in complex geometric shapes. If you would like to be a part of the journey, get in touch with us today.